Keywords: US ggeneric approval, Protonix, Actavis, Risperdal, Taro, Watson, Patent, Mucinex

US approval of generic Protonix for Actavis and Risperdal for Taro; Watson does not infringe patent

Article | 10 February 2011

Print This

Iceland headquartered Actavis says that it has received approval from the US Food and Drug Administration to market the gastro-intestinal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in